期刊文献+

双氢青蒿素抗癌药理作用机制的研究进展 被引量:9

Research progress on anti-tumor mechanisms of dihydroartemisinin
下载PDF
导出
摘要 双氢青蒿素是青蒿素的一种重要衍生物,是我国自行研发的抗疟新药。近年来,人们发现双氢青蒿素不但具有抗疟活性,而且具有良好的抗肿瘤效果,被认为是前景良好的抗肿瘤药。因此,综述目前双氢青蒿素抗肿瘤作用发生机制、靶点和通路的研究进展,主要包括癌细胞凋亡、内质网应激、癌细胞生长增殖、侵袭转移、肿瘤多药耐药以及细胞氧化损伤等方面。为抗肿瘤的基础研究、新药物研发以及药物设计提供参考和依据。 Dihydroartemisinin(DHA),an important artemisinin derivative,is one of new anti-malarial medicines developed by Chinese scientists.In recent years,it was reported that DHA is a promising anti-cancer medicine besides its extraordinary antimalarial activities.This article overviews the mechanisms,targets and signaling pathways of DHA based on the recent studies published in English and Chinese literatures.Specifically,this article covers some important topics,such as apoptosis,endoplasmic reticulum stress,the growth,proliferation and invasion of cancer cells,multidrug resistance and oxidative damage,in order to provide a better understanding to the anti-cancer effects of DHA and information for new drug development and design.
作者 周许薇 谭蔚锋 解方园 辛宝 陈俊 ZHOU Xuwei;TAN Weifeng;XIE Fangyuan;XIN Bao;CHEN Jun(Department of Pharmacy,Eastern Hepatobiliary Surgery Hospital Affiliated to Naval Medical University,Shanghai 200438,China;Department of Biliary Tract Surgery(Ⅳ),Eastern Hepatobiliary Surgery Hospital Affiliated to Naval Medical University,Shanghai 200438,China)
出处 《药学实践杂志》 CAS 2019年第3期206-211,278,共7页 Journal of Pharmaceutical Practice
关键词 双氢青蒿素 肿瘤 作用机制 dihydroartemisinin tumor mechanisms
  • 相关文献

参考文献3

二级参考文献19

  • 1Chen H, Sun B, Pan S, et al. Dihydroartemisinin inhibits growth of pancreatic cancer cells in vitro and in vivo [J]. Anticancer Drugs, 2009,20(2) :131 -140.
  • 2Kim S J, Kim MS, Lee JW, et al. Dihydroartemisi- nin enhances radiosensitivity of human glioma cells in vitro [ J ]. J Cancer Res Clin Oncol, 2006, 132(2): 129-135.
  • 3Galal AM, Gul W, Slade D, et al. Synthesis and e- valuation of dihydroartemisinin and dihydroarte- misitene acetal dimers showing antieaneer and antiprotozoal activity[ J ]. Bioorg Meal Chem, 2009, 17(2) : 741 -751.
  • 4Paik IH, Xie S, Shapiro TA, et al. Second genera- tion, orally active, antimalarial, artemisinin de- rived trioxane dimers with high stability, efficacy,and anticancer activity [ J ]. J Med Chem, 2006, 49(9) :2731 -2734.
  • 5Buommino E, Baroni A, Canozo N, et al. Arte- misinin reduces human melanoma cell migration by down-regulating cVI33 integrin and reducing metalloproteinase 2 production [ J ]. Invest New Drugs, 2009, 27(5). 412 -418.
  • 6Chen T, Li M, Zhang R, et al. Dihydroartemisinin induces apoptosis and sensitizes human ovarian cancer cells to carboplatin therapy[J ]. J Cell Mol Med, 2009, 13(7) : 1358 -1370.
  • 7Cai MB, Han HQ, Bei JX, et al. Expression of hu- man leukocyte antigen G is associated with prog- nosis in nasopharyngealcarcinoma[J]. Int J Bio Sci, 2012,8(6) :891 -900.
  • 8Zhang CZ, Pan Y, Cao Y, et al. Histone deacety- lase duced vo [J] nhibitors facilitate dihydroartemisinin-in- apoptosis in liver cancer in vitro and in vi- Plos One, 2012, 7 (6) : e39870.
  • 9Xue W, Zender L, Miething C, et al. Senescence and tumor clearance is triggered by p53 restora- tion in murine liver carcinomas [J ]. Nature, 2007,445(7128) : 656 -660.
  • 10Willoughby JA Sr, Sundar SN, Cheung M, et al. Artemisinin blocks prostate cancer growth and cell cycle progression by disrupting Spl interac- tions with the cyclin-dependent kinase-4 (CDK4) promoter and inhibiting CDK4 gene expression [J]. J Biol Chem, 2009, 284(4) : 2203 -2213.

共引文献42

同被引文献85

引证文献9

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部